ICD-9 Code 199.1

Other malignant neoplasm without specification of site

Not Valid for Submission

199.1 is a legacy non-billable code used to specify a medical diagnosis of other malignant neoplasm without specification of site. This code was replaced on September 30, 2015 by its ICD-10 equivalent.

ICD-9: 199.1
Short Description:Malignant neoplasm NOS
Long Description:Other malignant neoplasm without specification of site

Convert 199.1 to ICD-10

The following crosswalk between ICD-9 to ICD-10 is based based on the General Equivalence Mappings (GEMS) information:

  • C80.1 - Malignant (primary) neoplasm, unspecified

Code Classification

  • Neoplasms (140–239)
    • Malignant neoplasm of other and unspecified sites (190-199)
      • 199 Malignant neoplasm without specification of site

Information for Medical Professionals

Synonyms

  • Anemia in malignant neoplastic disease
  • Arthritis secondary to malignancy
  • Basal cell carcinoma - first recurrence
  • Basal cell carcinoma - multiple recurrences
  • Basal cell carcinoma - second recurrence
  • Basal cell carcinoma - third recurrence
  • Basal cell carcinoma with monster cells
  • Basal cell carcinoma with signet ring change
  • Cancer confirmed
  • Eaton Lambert syndrome with underlying malignancy
  • Erythema multiforme due to malignancy
  • Extraprostatic extension of tumor present, focal
  • Fracture of bone in neoplastic disease
  • Hormone receptor positive tumor
  • Human immunodeficiency virus disease resulting in multiple malignant neoplasms
  • Human immunodeficiency virus with secondary cancers
  • Hypermelanosis due to malignant adrenocorticotropic hormone/melanocyte stimulating hormone-secreting tumor
  • Intraepithelial squamous cell carcinoma
  • Invasion of neoplasm to visceral peritoneum
  • Malignant adenomatous neoplasm
  • Malignant carcinoid tumor
  • Malignant infiltration of skin by underlying tumor
  • Malignant neoplasm associated with acquired immunodeficiency syndrome
  • Malignant neoplastic disease
  • Malignant neoplastic disease in mother complicating childbirth
  • Malignant neoplastic disease in pregnancy
  • Malignant tumor involving an organ by direct extension from bladder
  • Malignant tumor involving an organ by direct extension from endometrium
  • Malignant tumor involving an organ by direct extension from fallopian tube
  • Malignant tumor involving an organ by direct extension from ovary
  • Malignant tumor involving an organ by direct extension from prostate
  • Malignant tumor involving an organ by direct extension from uterine cervix
  • Malignant tumor involving an organ by direct extension from uterus
  • Malignant tumor involving an organ by direct extension from vagina
  • Malignant tumor involving an organ by separate metastasis from bladder
  • Malignant tumor involving an organ by separate metastasis from endometrium
  • Malignant tumor involving an organ by separate metastasis from fallopian tube
  • Malignant tumor involving an organ by separate metastasis from ovary
  • Malignant tumor involving an organ by separate metastasis from prostate
  • Malignant tumor involving an organ by separate metastasis from uterine cervix
  • Malignant tumor involving an organ by separate metastasis from uterus
  • Malignant tumor involving an organ by separate metastasis from vagina
  • Malignant tumor of ill-defined site
  • Malignant tumor of unknown origin
  • Malignant tumor of unknown origin or ill-defined site
  • Mesothelioma
  • Metastasis from malignant melanoma of skin
  • Metastasis from malignant tumor of adrenal gland
  • Metastasis from malignant tumor of bladder
  • Metastasis from malignant tumor of bone
  • Metastasis from malignant tumor of breast
  • Metastasis from malignant tumor of bronchus
  • Metastasis from malignant tumor of buccal cavity
  • Metastasis from malignant tumor of cervix
  • Metastasis from malignant tumor of colon
  • Metastasis from malignant tumor of esophagus
  • Metastasis from malignant tumor of gallbladder
  • Metastasis from malignant tumor of kidney
  • Metastasis from malignant tumor of liver
  • Metastasis from malignant tumor of lung
  • Metastasis from malignant tumor of pancreas
  • Metastasis from malignant tumor of prostate
  • Metastasis from malignant tumor of rectum
  • Metastasis from malignant tumor of skin
  • Metastasis from malignant tumor of soft tissues
  • Metastasis from malignant tumor of stomach
  • Metastasis from malignant tumor of thyroid
  • Metastasis from malignant tumor of tongue
  • Metastasis from malignant tumor of uterus
  • Metastasis to adrenal gland of unknown primary
  • Metastasis to bladder of unknown primary
  • Metastasis to bone of unknown primary
  • Metastasis to brain of unknown primary
  • Metastasis to breast of unknown primary
  • Metastasis to bronchus of unknown primary
  • Metastasis to colon of unknown primary
  • Metastasis to eye of unknown primary
  • Metastasis to heart of unknown primary
  • Metastasis to kidney of unknown primary
  • Metastasis to large intestine of unknown primary
  • Metastasis to liver from adenocarcinoma
  • Metastasis to liver of unknown primary
  • Metastasis to lung from adenocarcinoma
  • Metastasis to lung of unknown primary
  • Metastasis to lymph node from squamous cell carcinoma
  • Metastasis to lymph node of unknown primary
  • Metastasis to mediastinum of unknown primary
  • Metastasis to multiple lymph nodes
  • Metastasis to ovary of unknown primary
  • Metastasis to pancreas of unknown primary
  • Metastasis to peritoneum of unknown primary
  • Metastasis to pleura of unknown primary
  • Metastasis to rectum of unknown primary
  • Metastasis to retroperitoneum of unknown primary
  • Metastasis to skin of unknown primary
  • Metastasis to small intestine of unknown primary
  • Metastasis to soft tissue of unknown primary
  • Metastasis to spleen of unknown primary
  • Metastasis to thymus of unknown primary
  • Metastasis to trachea of unknown primary
  • Metastasis to uterus of unknown primary
  • Metastasis to vagina of unknown primary
  • Metastasis to vertebral column of unknown primary
  • Metastatic adenocarcinoma of unknown origin
  • Metastatic basal cell carcinoma
  • Metastatic malignant neoplasm to apex of urinary bladder
  • Metastatic malignant neoplasm to dome of urinary bladder
  • Metastatic malignant neoplasm to lateral axillary lymph nodes
  • Metastatic malignant neoplasm to nasopharynx
  • Metastatic renal cell carcinoma
  • Metastatic squamous cell carcinoma
  • Mucinous adenocarcinoma cells present, comprising less than 50% of malignant cells
  • Oxyphilic adenocarcinoma
  • Pain from metastases
  • Panniculitis secondary to malignancy
  • Paraneoplastic peripheral neuropathy
  • Paraneoplastic sensorimotor neuropathy
  • Paraneoplastic sensory neuropathy
  • Pericarditis secondary to malignant primary tumor
  • Pleuropulmonary blastoma family tumor susceptibility syndrome
  • Polymyositis with malignant disease
  • Primary malignant neoplasm
  • Primary malignant neoplasm of unknown site
  • Renal involvement in malignant disease
  • Secondary malignant neoplasm of submaxillary gland
  • Secondary malignant neoplastic disease
  • Signet ring squamous cell carcinoma
  • Signet-ring cells present, comprising less that 50% of malignant cells
  • Spindle cell squamous cell carcinoma
  • Squamous cell carcinoma arising in chronic ulcer
  • Surgical deep margin is closest uninvolved margin to ductal carcinoma in situ
  • Surgical deep margin is closest uninvolved margin to malignant neoplasm
  • Surgical lateral margin is closest uninvolved margin to ductal carcinoma in situ
  • Surgical medial margin involved by malignant neoplasm
  • Surgical medial margin is closest uninvolved margin to ductal carcinoma in situ
  • Surgical superior margin involved by malignant neoplasm
  • Thrombophilia due to malignant neoplasm
  • Trichilemmal carcinoma
  • Verrucous squamous cell carcinoma
  • Widespread metastatic malignant neoplastic disease

Index to Diseases and Injuries

References found for the code 199.1 in the Index of Diseases and Injuries:


Information for Patients


Cancer

Also called: Carcinoma, Malignancy, Neoplasms, Tumor

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for where they start. For example, lung cancer starts in the lung, and breast cancer starts in the breast. The spread of cancer from one part of the body to another is called metastasis. Symptoms and treatment depend on the cancer type and how advanced it is. Most treatment plans may include surgery, radiation and/or chemotherapy. Some may involve hormone therapy, biologic therapy, or stem cell transplantation.

NIH: National Cancer Institute

  • Cancer
  • Cancer and lymph nodes
  • Cancer prevention: take charge of your lifestyle
  • Genetic testing and your cancer risk
  • Talking with a child about a parent's terminal illness
  • Understanding cancer staging
  • What if cancer comes back?
  • When your cancer treatment stops working

[Read More]

ICD-9 Footnotes

General Equivalence Map Definitions
The ICD-9 and ICD-10 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.

  • Approximate Flag - The approximate flag is on, indicating that the relationship between the code in the source system and the code in the target system is an approximate equivalent.
  • No Map Flag - The no map flag indicates that a code in the source system is not linked to any code in the target system.
  • Combination Flag - The combination flag indicates that more than one code in the target system is required to satisfy the full equivalent meaning of a code in the source system.

Index of Diseases and Injuries Definitions

  • And - The word "and" should be interpreted to mean either "and" or "or" when it appears in a title.
  • Code also note - A "code also" note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction.
  • Code first - Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists, there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.
  • Type 1 Excludes Notes - A type 1 Excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • Type 2 Excludes Notes - A type 2 Excludes note represents "Not included here". An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.
  • Includes Notes - This note appears immediately under a three character code title to further define, or give examples of, the content of the category.
  • Inclusion terms - List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • NEC "Not elsewhere classifiable" - This abbreviation in the Alphabetic Index represents "other specified". When a specific code is not available for a condition, the Alphabetic Index directs the coder to the "other specified” code in the Tabular List.
  • NOS "Not otherwise specified" - This abbreviation is the equivalent of unspecified.
  • See - The "see" instruction following a main term in the Alphabetic Index indicates that another term should be referenced. It is necessary to go to the main term referenced with the "see" note to locate the correct code.
  • See Also - A "see also" instruction following a main term in the Alphabetic Index instructs that there is another main term that may also be referenced that may provide additional Alphabetic Index entries that may be useful. It is not necessary to follow the "see also" note when the original main term provides the necessary code.
  • 7th Characters - Certain ICD-10-CM categories have applicable 7th characters. The applicable 7th character is required for all codes within the category, or as the notes in the Tabular List instruct. The 7th character must always be the 7th character in the data field. If a code that requires a 7th character is not 6 characters, a placeholder X must be used to fill in the empty characters.
  • With - The word "with" should be interpreted to mean "associated with" or "due to" when it appears in a code title, the Alphabetic Index, or an instructional note in the Tabular List. The word "with" in the Alphabetic Index is sequenced immediately following the main term, not in alphabetical order.